HAVE OUR BACKS
×
Sign Up
Already Registered?
face
lock_outline
THE FACTS
BIO
BIO
VOTES
VOTES
POSITIONS
POSITIONS
RATINGS
RATINGS
SPEECHES
SPEECHES
FUNDING
FUNDING
Please have our backs
No Thank You
Rosa DeLauro's Public Statements on Issue: Drugs
Office:
U.S. House (CT)
- District 3, Democratic
On The Ballot:
Running, Democratic for
U.S. House (CT)
- District 3
Track This Politician
Current Issue:
Drugs
Select Issue
All
Abortion
Agriculture and Food
Animals and Wildlife
Arts, Entertainment, and History
Business and Consumers
Campaign Finance
Civil Liberties and Civil Rights
Constitution
Criminal Justice
Death Penalty
Defense
Drugs
Economy and Fiscal
Education
Elections
Employment and Affirmative Action
Energy
Entitlements and the Safety Net
Environment
Executive Branch
Family
Federal, State and Local Relations
Finance and Banking
Food Processing and Sales
Foreign Affairs
Foreign Aid
Gambling and Gaming
Government Budget and Spending
Government Operations
Guns
Health Insurance
Health and Health Care
Higher Education
Housing and Property
Immigration
Indigenous Peoples
Infrastructure
Judicial Branch
K-12 Education
Labor Unions
Legal
Legislative Branch
Marijuana
Marriage
Military Personnel
Minors and Children
Monetary Policy
National Security
Natural Resources
Oil and Gas
Religion
Reproduction
Science
Senior Citizens
Sexual Orientation and Gender Identity
Stem Cell Research
Taxes
Technology and Communication
Trade
Transportation
Unemployed and Low-Income
Veterans
Women
Current Speech Type:
Speech
Select Speech Type
All
Debate
Executive Order
Floor Speech
Hearing
Interview
Issue Position
Letter
News Article
Op-Ed
Other
Pledge
Press Conference
Press Release
Social Media
Speech
Statement
Date Range
Start Date
End Date
Apply
Keyword Search
close
Reset Search
attach_money
Who is funding DeLauro?
Page 1 of 2
1
2
chevron_right
Date
Title
07/08/2009
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
07/08/2009
Providing for Consideration of H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010
01/12/2007
Medicare Prescription Drug Price Negotiation Act of 2007
01/12/2007
DeLauro Votes to Require Medicare to Negotiate With Drug Companies for Lower Drug Prices
01/10/2007
DeLauro, House and Senate Leaders Renew Effort to Allow Prescription Drug Importation
12/18/2006
DeLauro Urges FDA to Investigate Eli Lilly's Actions Involving Zyprexa
12/14/2006
GAO Report Echoes DeLauro's Concerns Over Direct-to-Consumer Advertising
11/14/2006
Sober Truth on Preventing Underage Drinking Act
11/14/2006
Bipartisan, Bicameral STOP Underage Drinking Act Passes U.S. House, DeLauro Announces
11/08/2006
Statement of CT Officials on Announced Closing of Bayer Pharmaceuticals
09/29/2006
Statement on IOM Recommendations for FDA Reform
09/22/2006
IOM Report Confirms FDA Lacks Power to Enforce Drug Regulations, Says DeLauro
09/21/2006
DeLauro: New Report Finds Nearly 90,000 Connecticut Medicare Beneficiaries at Risk of "Doughnut Hole"
07/17/2006
DeLauro: Are Conflicts of Interest Influencing Sales of Prescription Drugs, Medical Devices?
05/23/2006
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007
05/23/2006
Providing for Consideration of H.R. 5384, Agriculture, Rurual Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007
05/23/2006
Congressional Republicans Kill Important Drug Safety Safeguard, Said DeLauro
05/23/2006
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2007
05/23/2006
Agriculture, Rural Development, Food and Drug Adminstration, and Related Agendcies Appropriations Act, 2007
05/09/2006
Appropriations Committee Accepts DeLauro Amendment, Gives FDA Authority to Mandate Postmarket Studies
04/25/2006
Letter to Centers for Medicare and Medicaid Services Administrator Mark McClellan
04/24/2006
DeLauro Calls on FDA Head to Reconsider Position on Drug Safety
03/06/2006
DeLauro: Industry Influence Stronger than FDA Authority over Post-Market Drug Studies
02/17/2006
DeLauro: Increasing Industry Influence at FDA Will Not Solve Generic Application Backlog
02/06/2006
DeLauro, Local Pharmacist Call for Medicare Rx Drug Relief
Page 1 of 2
1
2
chevron_right
attach_money
Who is funding DeLauro?
clear
Log in
face
lock_outline
face
person
person_outline
email
lock
lock_outline
Enter the same password as above, for verification.
arrow_upward